Download PDF
Semin Respir Crit Care Med 2002; 23(6): 543-548
DOI: 10.1055/s-2002-36518
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Ocular Manifestations of Sarcoidosis

Deborah Bradley1 , Robert P. Baughman1 , Lawrence Raymond2 , Adam H. Kaufman2
  • 1Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio
  • 2Department of Ophthalmology, University of Cincinnati Medical Center, Cincinnati, Ohio
Further Information

Publication History

Publication Date:
07 January 2003 (online)

    Permissions and Reprints

ABSTRACT

Ophthalmic involvement in sarcoidosis may cause significant sight-threatening illness for patients. Studies of patients with histologically proven sarcoidosis have found 25 to 50% of patients to have ocular manifestations.[1] The frequency in which eye disease is seen and the course that it takes vary with age, race, and geography.[2] [3] This article discusses relevant aspects of the ocular manifestations of sarcoidosis for the internist and pulmonologist. Overall disease presentation, specific types of ocular involvement, evaluation strategies, and treatment considerations are discussed.

KEYWORD

iritis - uveitis - vitritis - pars planitis - scleritis - ocular manifestations - sarcoidosis

REFERENCES

  • 1 Hunter D G, Foster C S. Ocular manifestations of sarcoidosis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology Philadelphia: WB Saunders 1994: 1217-1224
    Google Scholar
  • 2 Izumi T. Symposium: population differences in clinical features and prognosis of sarcoidosis throughout the world.  Sarcoidosis . 1992;  9(suppl) S105-S118
    PubMedGoogle Scholar
  • 3 Angi M R, De Caro G, Bergamo L. Low prevalence of uveitis in Italian sarcoidosis patients.  Sarcoidosis . 1991;  8 181-182
    PubMedGoogle Scholar
  • 4 Stavrou P, Foster C S. Sarcoidosis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis Philadelphia: WB Saunders 2002: 710-725
    Google Scholar
  • 5 James D G. Ocular sarcoidosis.  Ann N Y Acad Sci . 1986;  465 551-563
    PubMedGoogle Scholar
  • 6 Raymond L A, Spaulding A G, Vilter R W. Peripheral retinal neovascularization in sarcoidosis with thalassemia.  Ann Ophthalmol. 978;  10 745-748
    PubMedGoogle Scholar
  • 7 Hoover D L, Khan J A, Giangiacomo J. Pediatric ocular sarcoidosis.  Surv Ophthalmol . 1986;  30 215-228
    PubMedGoogle Scholar
  • 8 Rothova A. Ocular involvement in sarcoidosis.  Br J Ophthalmol . 2000;  84 110-116
    CrossrefPubMedGoogle Scholar
  • 9 Blau E B. Familial granulomatous arthritis, iritis, and rash.  J Pediatr . 1985;  107 689-693
    PubMedGoogle Scholar
  • 10 Manouvrier-Hanu S, Puech B, Peitte F. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature.  Am J Med Gen . 1998;  76 217-221
    CrossrefPubMedGoogle Scholar
  • 11 Tromp G, Kuivaniemi H, Raphael S. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16.  Am J Hum Genet . 1996;  59 1097-1107
    PubMedGoogle Scholar
  • 12 Siltzbach L E, James D G, Neville E. Course and prognosis of sarcoidosis around the world.  Am J Med . 1974;  57 847-852
    CrossrefPubMedGoogle Scholar
  • 13 Yamaguchi M, Hosada Y, Sasaki R. Epidemiological study on sarcoidosis in Japan: recent trends in incidence and prevalence rates and changes in epidemiological features.  Sarcoidosis . 1989;  6 138
    PubMedGoogle Scholar
  • 14 Rothova A, Alberts C, Glasius E. Risk factors for ocular sarcoidosis.  Doc Ophthalmol . 1989;  72 287-296
    CrossrefPubMedGoogle Scholar
  • 15 Samson C M, Waheed N, Baltatzis S. Methotrexate therapy for chronic noninfectious uveitis.  Ophthalmology . 2001;  108 1134-1139
    CrossrefPubMedGoogle Scholar
  • 16 Baughman R P, Winget D B, Lower E E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.  Sarcoidosis Vasc Diffuse Lung Dis . 2000;  17 60-66
    PubMedGoogle Scholar
  • 17 Baughman R P. Methotrexate for sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1998;  15 147-149
    PubMedGoogle Scholar
  • 18 Baughman R P, Lower E E. A clinical approach to the use of methotrexate for sarcoidosis.  Thorax . 1999;  54 742-746
    CrossrefPubMedGoogle Scholar
  • 19 Dev S, McCallum R M, Jaffe G J. Methotrexate treatment for sarcoid-associated panuveitis.  Ophthalmology . 1999;  106 111-118
    CrossrefPubMedGoogle Scholar
  • 20 Dana M R, Merayo-Lloves J, Schaumberg D A. Prognosticators for visual outcome in sarcoid uveitis.  Ophthalmology . 1996;  103 1846-1853
    CrossrefPubMedGoogle Scholar
  • 21 Baughman R P, Lower E E, Bradley D A, Kaufman A H. Use of cytotoxic therapy for chronic ophthalmic sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16(suppl) S17
    PubMedGoogle Scholar
  • 22 Baughman R P, Ohmichi M, Lower E E. Combination therapy for sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 2001;  18 133-137
    PubMedGoogle Scholar
  • 23 Edelsten C, Pearson A, Joynes E. The ocular and systemic prognosis of patients presenting with sarcoid uveitis.  Eye . 1999;  13(pt 6) 748-753
    CrossrefPubMedGoogle Scholar
  • 24 Kaye G B, Salmon J F, Isaacs S. Risk factors for uveitis in sarcoidosis.  S Afr Med J . 1993;  83 342-344
    PubMedGoogle Scholar
  • 25 Jabs D A, Johns C J. Ocular involvement in chronic sarcoidosis.  Am J Ophthalmol . 1986;  102 297-301
    PubMedGoogle Scholar
  • 26 Martinetti M, Tinelli C, Kolek V. ``The Sarcoidosis Map'': a joint survey of clincal and immunogenetic findings in two European countries.  Am J Respir Crit Care Med . 1995;  152 557-564
    PubMedGoogle Scholar
  • 27 Merritt J C, Whitsett C F, Daffin L. HLA-A, -B, and -DR antigenic factors in ocular sarcoidosis.  Am J Ophthalmol . 1983;  96 396-397
    PubMedGoogle Scholar
  • 28 Baughman R P, Teirstein A S, Judson M A. A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis.  Am J Respir Crit Care Med . 2001;  164 1885-1889
    CrossrefPubMedGoogle Scholar
  • 29 Rothova A, Suttorp-van Schulten S M, Frits T W. Causes and frequency of blindness in patients with intraocular inflammatory disease.  Br J Ophthalmol . 1996;  80 332-336
    CrossrefPubMedGoogle Scholar
  • 30 Dresner M S, Brecher R, Henkind P. Ophthalmology consultation in the diagnosis and treatment of sarcoidosis.  Arch Intern Med . 1986;  146 301-304
    CrossrefPubMedGoogle Scholar
  • 31 Hunninghake G W, Costabel U, Ando M. ATS/ ERS/WASOG statement on sarcoidosis.  Am J Resp Crit Care Med 1999;160:736-755; Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 149-173
    PubMedGoogle Scholar
  • 32 Johns C J, Michele T M. The clinical management of sarcoidosis: a 50-year experience at the Johns Hopkins Hospital.  Medicine (Baltimore) . 1999;  78 65-111
    CrossrefPubMedGoogle Scholar
  • 33 Obenauf C D, Shaw H E, Sydnor C F. Sarcoidosis and its ophthalmic manifestations.  Am J Ophthalmol . 1978;  86 648-655
    PubMedGoogle Scholar
      >